Skip to content

Insider · CIK 0001853109

Behrad Derakhshan

officer

Files at EWTX (Edgewise Therapeutics, Inc.). First filing Feb 7, 2025, latest May 7, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $328k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

EWTX: Edgewise Therapeutics, Inc.

EWTXOct 9, 2026 · close 39.06

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
EWTXsell 6
Edgewise Therapeutics, Inc.
$28k
1,691 shares
-8%+48% from low-54% from high
19Weak
EWTXsell 410b5-1
Edgewise Therapeutics, Inc.
$300k
10,000 shares
-37%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+5,209$0.00$022,046May 7, 2025
May 2, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock
-1,691$16.45$28k20,355May 7, 2025
May 1, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Restricted Stock Unitsderivative
-5,209$0.00$00May 7, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Common Stock
+10,000$1.93$19k26,837Feb 7, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-10,000$30.03$300k16,837Feb 7, 2025
Feb 5, 2025EWTX
Edgewise Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative
-10,000$0.00$092,929Feb 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Behrad Derakhshan: insider trades and track record | InsiderTell